Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2025
Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activityBshra A Alsfouk, Walid E Elgammal, Hazem Elkady, et al.Bioorganic Chemistry|December 18, 2020
Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinomaIbrahim H Eissa, Mohammed K Ibrahim, Ahmed M Metwaly, et al.Computational Biology and Chemistry|September 27, 2024
Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studiesHazem Elkady, Walid E Elgammal, Hazem A Mahdy, et al.RSC Advances|November 7, 2024
Design, synthesis, and evaluation of novel thiadiazole derivatives as potent VEGFR-2 inhibitors: a comprehensive <i>in vitro</i> and <i>in silico</i> studyIbrahim H Eissa, Walid E Elgammal, Hazem A Mahdy, et al.Chemical Biology & Drug Design|March 26, 2026
Thiadiazole-Derived VEGFR-2 Inhibitors: From Design to Anticancer EvaluationAisha A Alsfouk, Eslam B Elkaeed, Hazem Elkady, et al.Chemical Biology & Drug Design|July 21, 2025
New Thiadiazole-Benzenesulfonamide Hybrids as Dual B-Raf/VEGFR-2 Inhibitors With Promising Anti-Hepatic Cancer ActivityAisha A Alsfouk, Hazem Elkady, Saber M Hassan, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|December 28, 2021
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studiesHazem Elkady, Alaa Elwan, Hesham A El-Mahdy, et al.Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.International Journal of Molecular Sciences|August 12, 2023
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide AnalogsReda R Mabrouk, Abdallah E Abdallah, Hazem A Mahdy, et al.Future Medicinal Chemistry|February 25, 2025
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and <i>in silico</i> studiesReda R Mabrouk, Hazem A Mahdy, Abdallah E Abdallah, et al.Pageof 5